Stress Reduction Program Based on Mindfulness for Patients With Discopathies

May 5, 2022 updated by: Fundación Eduardo Anitua
This study evaluates the influence of stress on inflammation and the symptomatology of the patient with back pain. Mindfulness Based Stress Reduction (MBSR) will be used in half of participants, a validated psychopedagogical intervention for stress reduction, and the participants assigned to the control group will follow the usual treatment, according to their diagnosis.

Study Overview

Status

Completed

Conditions

Detailed Description

The Mindfulness based stress reduction (MBSR) is a psycho-educational program of stress reduction based on mindfulness. It consists of a program of 30 hours of duration divided into 9 sessions with a weekly frequency of 2.5 h and an intensive session between the week 6 and 7 of the program with a duration of 7.5 hours. Each week, the theoretical contents that are necessary to understand the attention development practices will be covered. In addition, basic concepts of the psychobiology and psychology of stress and pain will be explained. The subjects will have a homework load of approximately 45 minutes per day during the intervention program.

Study Type

Interventional

Enrollment (Actual)

96

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alava
      • Vitoria, Alava, Spain, 01007
        • Fundación Eduardo Anitua
    • Colmenarejo
      • Madrid, Colmenarejo, Spain, 28070
        • Instituto de Investigación y Formación en Ciencias Cognitivas - Nirakara
    • Somosaguas
      • Madrid, Somosaguas, Spain, 28223
        • Facultad de Psicología de la Universidad Complutense de Madrid.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • To be diagnosed with symptomatic disc disease (Participants must provide a medical report that certifies the discopathy).
  • Normal or moderate mobility
  • Normal cognitive state
  • Patients who have previously read and signed the informed consent.
  • Patients that are capable and willing to comply with the study procedures.

Exclusion Criteria:

  • Serious psychopathologies
  • Suicidal thoughts.
  • Deep depression
  • Psychosis
  • Drug addiction
  • Very limited functional capacity and cognitive impairment: Patientsconfined in a bed or a chair. They need the help of a third person.
  • Do not incorporate during the program any clinical, psychological or pharmacological treatments different from those ones that are normally used to controlled the pain, or any drastic changes in lifestyle.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mindfulness Based Stress Reduction (MBSR)
Program of 30 hours of duration divided into 9 sessions with a weekly frequency of 2.5 h and an intensive session between week 6 and 7 of the program with a duration of 7.5 hours.

Psycho-educational program of stress reduction based on mindfulness. Program of 30 hours of duration divided into 9 sessions with a weekly frequency of 2.5 h and an intensive session between week 6 and 7 of the program with a duration of 7.5 hours.

Each week the theoretical contents necessary to understand the attention development practices proposed in mindfulness-based interventions will be covered. In addition, basic concepts of the psychobiology and psychology of stress and pain are explained. The subjects will have a homework load of approximately 45 minutes per day during the duration of the intervention.

No Intervention: Control
Participants assigned to the control group will follow the usual treatment, according to their diagnosis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stress change
Time Frame: Baseline and Six months
Measured with the variation of cortisol in blood. These samples are obtained from a blood test that will be done to the participants before and after starting the experimental and control programs.
Baseline and Six months
Variation of cytokines
Time Frame: Baseline and Six months
((TNF) -α and interleukin (IL) -1β, IL-6 and IL17), as an approximate biomarker of inflammation. Bio-chemical markers of the discopathy: Cytokines ((TNF) -α, interleukin (IL) -1β, IL-6 and IL-17). These samples are obtained from a blood test that will be done to the participants before and after starting the experimental and control programs.
Baseline and Six months
Variation of the nocturnal apnea index.
Time Frame: Baseline and Six months
Sleep and breathing analysis: The performance of the sleep and breathing registration tests will be carried out in the patient's home. The sleep study will be done with a validated respiratory polygraphy (BTI-APNiA®). The sleep analysis will be controlled by a sleep technician and supervised by a sleep medicine specialist. The sleep analysis will be done to the participants before and after starting the experimental and control programs.
Baseline and Six months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Five Facet Mindfulness Questionnaire (FFMQ)
Time Frame: Baseline and Six months
39 items scale that offers a total score of a person's level of mindfulness.
Baseline and Six months
Self-Compassion Scale (SCS)
Time Frame: Baseline and Six months
Evaluates the person's ability to be kind and understanding with themselves. The scale consists of 26 items scored on a 5-point likert scale.
Baseline and Six months
Perceived Stress Scale (PSS)
Time Frame: Baseline and Six months
Evaluates the level of perceived stress during the last month. It consists of 14 items scored on a Likert scale from 0 to 4.
Baseline and Six months
DASS-21
Time Frame: Baseline and Six months
Scale designed to assess negative mood by means of three subscales: stress, anxiety and depression. The scale has 21 items scored on a Likert scale from 0 to 3.
Baseline and Six months
Chronic Pain Grade Scale (CPGS; 90)
Time Frame: Baseline and Six months
Scale that assesses the intensity of pain and disability caused by pain. It is a widely used measure for the evaluation of chronic musculoskeletal pain and back pain. The scale consists of 7 items scored on a Likert scale from 0 to 10.
Baseline and Six months
Brief Pain Inventory (BPI)
Time Frame: Baseline and Six months
It measures both the intensity of pain (sensory dimension) and the interference of pain in the patient's life (reactive dimension) in patients with chronic pain caused by osteoarthritis, back pain and cancer.
Baseline and Six months
Chronic Pain Acceptance Questionnaire-Revised (CPAQ-R)
Time Frame: Baseline and Six months
Instrument designed to assess the acceptance of pain. The scale consists of 20 items scored on a Likert scale from 0 to 6.
Baseline and Six months
Pain Catastrophising Scale (PCS)
Time Frame: Baseline and Six months
Evaluates the tendency to magnify the threat of a painful stimulus and the feeling of helplessness in the presence of pain, as well as the inability to prevent or inhibit thoughts related to pain (both before, during, and after the painful event). The scale consists of 13 items scored on a Likert scale from 0 to 4.
Baseline and Six months
Brief Fatigue Inventory (BFI)
Time Frame: Baseline and Six months
The objective of this scale is to assess the severity of fatigue and the impact of fatigue caused by pain in the daily functioning of people. The scale consists of 9 items scored on a scale likert type from 0 to 10.
Baseline and Six months
Pain Self-Efficacy Questionnaire (PSEQ)
Time Frame: Baseline and Six months
Evaluates to what extent a person with pain believes they are capable of performing their daily activities regardless of their pain. The scale consists of 10 items scored on a scale likert type from 0 to 6.
Baseline and Six months
Survey of Pain Attitudes - Brief (SOPA-B)
Time Frame: Baseline and Six months
Evaluates the patient's attitude to seven dimensions of the experience of chronic pain: control of pain, disability associated with pain, medical cues of pain, request for help from others when in pain, medication for pain, the influence of emotions on pain and pain as an indicator of physical damage. The scale consists of 30 items scored on a Likert scale from 0 to 4.
Baseline and Six months
Pain Coping Inventory (PC)
Time Frame: Baseline and Six months
Instrument designed to evaluate the pain coping strategies used by patients with chronic pain. The scale consists of 34 items scored on a Likert scale from 1 to 4.
Baseline and Six months
Short Form-36 Bodily Pain Scale (SF-36 BPS)
Time Frame: Baseline and Six months
It is one of the eight subscales of the SF-36 questionnaire (Ware, Kosinski & Keller, 1994) designed as a generic measure of health status for population studies.
Baseline and Six months
Pain and Sleep Questionnaire (PSQ)
Time Frame: Baseline and Six months
Evaluates the impact of chronic pain on sleep quality. The scale consists of 8 items scored on a visual analog scale from 0 to 100.
Baseline and Six months
Satisfaction with Life questionnaire (SWLS)
Time Frame: Baseline and Six months
5-item brief scale designed to measure a person's overall cognitive judgments about their satisfaction with life.
Baseline and Six months
WHO-5 Well Being Index
Time Frame: Baseline and Six months
5 item scale designed to evaluate the subjective psychological well-being of the person.
Baseline and Six months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 3, 2019

Primary Completion (Actual)

March 30, 2020

Study Completion (Actual)

March 30, 2020

Study Registration Dates

First Submitted

April 2, 2019

First Submitted That Met QC Criteria

April 10, 2019

First Posted (Actual)

April 11, 2019

Study Record Updates

Last Update Posted (Actual)

May 6, 2022

Last Update Submitted That Met QC Criteria

May 5, 2022

Last Verified

July 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FIBEA-01-EC/18/MIND

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Back Pain

Clinical Trials on Mindfulness Based Stress Reduction (MBSR)

Subscribe